Thyroid Ultrasound Results and Management

Introduction to Thyroid Ultrasound Findings

The American College of Radiology recommends that thyroid nodules with benign ultrasound characteristics, such as those classified as TI-RADS 2, do not require biopsy, regardless of size, due to their extremely low malignancy risk of less than 2% 1
The presence of a heterogeneous thyroid appearance is consistent with chronic thyroiditis, a common autoimmune condition that causes inflammation of the thyroid gland, and does not increase the risk of thyroid cancer 1

Current guidelines from the American College of Radiology do not recommend fine needle aspiration biopsy for nodules less than 1 cm unless they have highly suspicious ultrasound features or the patient has high-risk clinical factors, with a malignancy risk of approximately 1-2% for TI-RADS 2 nodules 1, 2
Subcentimeter nodules with benign features have a false-negative rate of only 1.5% 1

The American College of Radiology states that reactive lymph nodes, commonly seen with chronic thyroiditis, do not suggest malignancy and are characterized by the presence of normal fatty hila 3
Suspicious lymph nodes would show loss of the fatty hilum, microcalcifications, cystic change, or abnormal blood flow patterns, which are not present in cases with benign lymph nodes 4

A history of head and neck radiation increases the malignancy risk 7-fold, and other high-risk factors include family history of thyroid cancer, age less than 15 years, rapidly growing nodule, firm or fixed nodule on palpation, and vocal cord paralysis or compressive symptoms 1

The American College of Radiology recommends against unnecessary repeat imaging for TI-RADS 2 nodules, as they have a low risk of malignancy 1
Thyroid function tests, such as TSH, T3, and T4, do not predict malignancy, as most thyroid cancers occur in patients with normal thyroid function 1
Overdiagnosis is a significant problem, with approximately 77% of thyroid cancers diagnosed in the United States representing overdiagnosis of indolent cancers that would never cause harm 3

Patients should report new symptoms, such as difficulty swallowing, breathing problems, voice changes, rapid nodule growth, or a new palpable neck mass, to their physician for re-evaluation 1
Routine thyroid function monitoring may be appropriate if symptoms of thyroid dysfunction develop, and no routine imaging surveillance is needed for TI-RADS 2 nodules unless new clinical concerns arise 1, 3